Jazz Pharmaceuticals plc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC JAZZ

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

148,323

Value ($000)

25,215

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	25,215	0.0%	148,323	12/31/2025
2025 Q3	11/14/2025	22,365	0.0%	169,687	9/30/2025
2025 Q2	8/14/2025	29,082	0.0%	274,051	6/30/2025
2025 Q1	5/19/2025	24,479	0.0%	197,174	3/31/2025
2024 Q4	2/14/2025	23,302	0.0%	189,220	12/31/2024
2024 Q3	11/14/2024	19,394	0.0%	174,078	9/30/2024
2024 Q2	8/14/2024	7,894	0.0%	73,966	6/30/2024
2024 Q1	5/15/2024	29,104	0.0%	241,685	3/31/2024
2023 Q4	2/14/2024	28,644	0.0%	232,880	12/31/2023
2023 Q3	11/13/2023	30,687	0.0%	237,072	9/30/2023
2023 Q2	8/11/2023	43,445	0.0%	296,897	6/30/2023
2023 Q1	5/15/2023	43,445	0.0%	296,897	3/31/2023
2022 Q4	2/14/2023	48,147	0.0%	302,221	12/31/2022
2022 Q3	11/14/2022	38,523	0.0%	289,017	9/30/2022
2022 Q2	8/12/2022	45,107	0.0%	289,130	6/30/2022
2022 Q1	5/16/2022	51,061	0.0%	328,006	3/31/2022
2021 Q4	2/14/2022	71,464	0.0%	560,941	12/31/2021
2021 Q3	11/15/2021	43,857	0.0%	336,816	9/30/2021
2021 Q2	8/16/2021	64,398	0.0%	362,519	6/30/2021
2021 Q1	5/14/2021	58,058	0.0%	353,213	3/31/2021
2020 Q4	3/1/2021	64,807	0.0%	392,648	12/31/2020
2020 Q3	11/13/2020	54,355	0.0%	381,199	9/30/2020
2020 Q2	8/14/2020	42,065	0.0%	381,228	6/30/2020
2020 Q1	5/15/2020	40,435	0.0%	405,403	3/31/2020
2019 Q4	2/14/2020	61,628	0.0%	412,833	12/31/2019
2014 Q1	5/23/2014	6,573	0.0%	47,398	3/31/2014
2013 Q4	1/31/2014	12,264	0.0%	96,898	12/31/2013